1-8 of 8
Hongying Li
Close
Sort by
Journal Articles

Immunotherapeutic Targeting of ROR1-Dependent, Non-Canonical Wnt5a-Signaling By Cirmtuzumab: A First-in-Human Phase I Trial for Patients with Intractable Chronic Lymphocytic Leukemia

Michael Y. Choi, MD, George F. Widhopf, II, PhD, Jian Yu, PhD, Reilly L Kidwell, BS, BA, CCRC, Laura Z. Rassenti, PhD, Charlene Gutierrez, Susette Gorak, Tiffany Juarez, PhD, Emily Pittman, PhD, Hongying Li, PhD, Karen Messer, PhD, Charles Prussak, PhD, Januario E. Castro, MD, Catriona Jamieson, MD PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 3224.
https://doi.org/10.1182/blood.V128.22.3224.3224
Published: 2016
Journal Articles

Inhibition of Casein Kinase 2 Impairs Wnt Signaling and Cell Survival in Chronic Lymphocytic Leukemia

Christina Wu, PhD, Fitzgerald S Lao, BS, Emily Nan, Hongying Li, PhD, Michael Y. Choi, MD, Karen Messer, PhD, Dennis A. Carson, MD
Journal: Blood
Blood (2016) 128 (22): 2050.
https://doi.org/10.1182/blood.V128.22.2050.2050
Published: 2016
Journal Articles

Cirmtuzumab (UC-961), a First-in-Class Anti-ROR1 Monoclonal Antibody: Planned Interim Analysis of Initial Phase 1 Cohorts

Michael Y. Choi, MD, George F. Widhopf, II, PhD, Januario Castro, MD, Hongying Li, PhD, Reilly L Kidwell, BS, BA, CCRC, Sam C Zhang, B.A., Tiffany Juarez, PhD, Susette Gorak, Laura Z. Rassenti, PhD, Karen Messer, PhD, Charles Prussak, PhD, Catriona HM Jamieson, MD PhD, Thomas J. Kipps, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1736.
https://doi.org/10.1182/blood.V126.23.1736.1736
Published: 2015
Journal Articles

Inhibition of Wnt Signaling By Dimethyl Fumarate Results in in Vitro and in Vivo Clearance of Chronic Lymphocytic Leukemia Cells and Has Additive Activity with Ibrutinib

Christina C.N. Wu, PhD, Fitzgerald Lao, Hongying Li, PhD, Laura Rassenti, PhD, Thomas J. Kipps, MD, Karen Messer, PhD, Dennis A. Carson, MD, Michael Y. Choi, MD
Journal: Blood
Blood (2014) 124 (21): 4683.
https://doi.org/10.1182/blood.V124.21.4683.4683
Published: 2014
Journal Articles

miR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1

Marek Mraz, Liguang Chen, Laura Z. Rassenti, Emanuela M. Ghia, Hongying Li, Kristen Jepsen, Erin N. Smith, Karen Messer, Kelly A. Frazer, Thomas J. Kipps
Journal: Blood
Blood (2014) 124 (1): 84–95.
https://doi.org/10.1182/blood-2013-09-527234
Published: 2014
Includes: Supplemental data
Journal Articles

Lenalidomide and Rituximab For The Treatment Of Patients With Relapsed Or Refractory Chronic Lymphocytic Leukemia: Results Of Planned Interim Analysis

Michael Y. Choi, MD, Januario E. Castro, M.D., Sheila Hoff, RN, Hongying Li, PhD, Laura Rassenti, PhD, Danelle F. James, M.D., M.A.S., Karen Messer, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5299.
https://doi.org/10.1182/blood.V122.21.5299.5299
Published: 2013
Journal Articles

Impact of Deletion 17p On the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma.

Caitlin L. Costello, M.D., Edward D. Ball, M.D., Sue Corringham, R.N., Hongying Li, PhD, Karen Messer, PhD
Journal: Blood
Blood (2012) 120 (21): 3099.
https://doi.org/10.1182/blood.V120.21.3099.3099
Published: 2012
Journal Articles

The Target Genes and Prognostic Significance of Mir-150 in Chronic Lymphocytic Leukemia

Marek Mraz, MD, PhD, Laura Z. Rassenti, Ph.D., Emanuela M. Ghia, PhD, Liguang Chen, MD, PhD, Jessie-Farah Fecteau, Ph.D., Sarka Pospisilova, Dr, PhD, Hongying Li, PhD, Karen Messer, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3859.
https://doi.org/10.1182/blood.V120.21.3859.3859
Published: 2012